Daihan Pharmaceutical Co.Ltd (023910) — Long-term Investment Intensity
Daihan Pharmaceutical Co.Ltd (023910) has a Long-term Investment Intensity of 3.4% as of December 2019. Long-term investments of ₩8.44 Billion represent 3.4% of total assets of ₩246.85 Billion. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check Daihan Pharmaceutical Co.Ltd (023910) asset resilience to evaluate the company's liquid asset resilience ratio.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Daihan Pharmaceutical Co.Ltd Long-term Investment Intensity (2014–2019)
This chart shows how Daihan Pharmaceutical Co.Ltd's Long-term Investment Intensity has evolved across 6 annual periods from 2014 to 2019. As of December 2019, the intensity stands at 3.4%, reflecting long-term investments of ₩8.44 Billion against total assets of ₩246.85 Billion KRW. For the complete balance sheet picture, see 023910 total asset value.
Annual Long-term Investment Intensity for Daihan Pharmaceutical Co.Ltd (2014–2019)
The table below presents the year-by-year Long-term Investment Intensity for Daihan Pharmaceutical Co.Ltd from 2014 to 2019, covering 6 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. Read Daihan Pharmaceutical Co.Ltd (023910) total liabilities for a breakdown of total debt and financial obligations.
| Year | LT Investment Intensity | LT Investments (KRW) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2019 | 3.4% | ₩8.44 Billion | ₩246.85 Billion | ▲ +0.1 pp |
| 2018 | 3.3% | ₩7.81 Billion | ₩234.75 Billion | ▲ +0.2 pp |
| 2017 | 3.1% | ₩5.74 Billion | ₩184.40 Billion | ▼ -0.3 pp |
| 2016 | 3.4% | ₩5.43 Billion | ₩160.31 Billion | ▲ +0.6 pp |
| 2015 | 2.8% | ₩3.87 Billion | ₩138.83 Billion | ▲ +0.1 pp |
| 2014 | 2.7% | ₩3.55 Billion | ₩131.61 Billion | — |